| Ytd | -28.39% | |
| 1y | -45.40% |
| Open | 1.49 | Prev Close | 1.47 | Low | 1.43 | High | 1.49 | Mkt Cap | 389.90M |
| Vol | 309.91K | Avg Vol | 1.38M | EPS | -1.09 | P/E | -1.34 | Forward P/E | -3.08 |
| Beta | 2.04 | Short Ratio | 2.48 | Inst. Own | 77.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 1.60 | 200-d Avg | 1.54 | 1yr Est | 10.45 |
AUTL News
Autolus Therapeutics maintains a Buy rating, driven by ongoing execution in CAR T-cell therapy, espe
Oncology innovation is reshaping cancer care as AI, immunotherapy and targeted therapies fuel pipeli
LONDON & GAITHERSBURG, Md., July 01, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL
LONDON and GAITHERSBURG, Md., June 25, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AU
LONDON and GAITHERSBURG, Md., June 12, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AU
After losing some value lately, a hammer chart pattern has been formed for Autolus Therapeutics (AUT
Autolus Therapeutics PLC Sponsored ADR (AUTL) reached a significant support level, and could be a go
LONDON and GAITHERSBURG, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUT
LONDON and GAITHERSBURG, Md., May 21, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUT
TOYO shares rose 13.7% after beating earnings expectations. Other top gainers include JLHL, RAMP, HI
Autolus Therapeutics plc (AUTL) Q1 2026 Earnings Call Transcript
Autolus Therapeutics NASDAQ: AUTL reported higher first-quarter 2026 product revenue and said its co
AUCATZYL® (obecabtagene autoleucel; obe-cel) net product revenue of $26.2 million for the first quar
LONDON and GAITHERSBURG, Md., May 05, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUT
Initiative focused on driving gross profit margin and path to profitability for the ALL business Com
LONDON and GAITHERSBURG, Md., April 21, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: A
Autolus Therapeutics (NASDAQ: AUTL) hosted an investor event focused on its acute lymphoblastic leuk
Autolus Therapeutics plc (AUTL) Discusses Advances in B-cell Precursor Acute Lymphoblastic Leukemia
LONDON and GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: A
US stock futures up, Nasdaq 100 gains 100 pts. Service Properties Trust (SVC) drops 4% in pre-market
Autolus Therapeutics plc maintains a Hold rating due to a challenging risk/reward profile despite st
Autolus Therapeutics plc (AUTL) Q4 2025 Earnings Call Transcript
LONDON and GAITHERSBURG, Md., March 27, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: A
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Wednesday's session saw 269 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Friday, 431 companies hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Thursday